Xiangxue PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 3/6
Xiangxue PharmaceuticalLtd has a total shareholder equity of CN¥2.3B and total debt of CN¥2.4B, which brings its debt-to-equity ratio to 104.3%. Its total assets and total liabilities are CN¥8.2B and CN¥6.0B respectively. Xiangxue PharmaceuticalLtd's EBIT is CN¥101.8M making its interest coverage ratio 521.5. It has cash and short-term investments of CN¥121.3M.
Key information
104.3%
Debt to equity ratio
CN¥2.38b
Debt
| Interest coverage ratio | 521.5x |
| Cash | CN¥121.27m |
| Equity | CN¥2.29b |
| Total liabilities | CN¥5.96b |
| Total assets | CN¥8.24b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 300147's short term assets (CN¥1.8B) do not cover its short term liabilities (CN¥5.2B).
Long Term Liabilities: 300147's short term assets (CN¥1.8B) exceed its long term liabilities (CN¥802.7M).
Debt to Equity History and Analysis
Debt Level: 300147's net debt to equity ratio (99%) is considered high.
Reducing Debt: 300147's debt to equity ratio has increased from 91.8% to 104.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable 300147 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: 300147 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 41.5% per year.